Back to the Basics

Exciting preclinical data have led scientists to a search for a "bypass in a test tube," a drug that stimulates the growth of blood vessels. However, efforts in the past year to stimulate angiogenesis in patients have been discouraging. "We need to go back to the lab and do some more preclinical experiments and gain a better understanding of the mechanism," says Napoleone Ferrara of the department of molecular oncology at Genentech Inc., South San Francisco, Calif. When the leg or heart a

Written byNadia Halim
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Exciting preclinical data have led scientists to a search for a "bypass in a test tube," a drug that stimulates the growth of blood vessels. However, efforts in the past year to stimulate angiogenesis in patients have been discouraging. "We need to go back to the lab and do some more preclinical experiments and gain a better understanding of the mechanism," says Napoleone Ferrara of the department of molecular oncology at Genentech Inc., South San Francisco, Calif.

When the leg or heart arteries are blocked, the tissues suffer an injury called ischemia from lack of oxygen. Restoring blood flow to the ischemic area is the most effective way to relieve symptoms, such as pain, and reduce long-term risk of heart attack. The body's natural healing process may initiate development of collateral circulation through angiogenesis. When the body's effort to restore blood flow fails or is insufficient, doctors intervene with either ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems